• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Prevent Blindness plans Eyes on Capitol Hill program on March 1-2

Article

The organization uses its Eyes on Capitol Hill program to educate lawmakers and their staff on a variety of vision health issues, including vision health inequities, the need for improved vision surveillance, the impact of community eye health programs, and disparities in access to affordable eyecare services.

Prevent Blindness will hold its 17th annual Eyes on Capitol Hill advocacy day as a virtual event on March 1-2, 2022.

According to the organization, it created the Eyes on Capitol Hill program to provide patients, caregivers, allied personnel, and medical professionals direct access to their elected officials, in an effort to educate lawmakers and their staff on a variety of vision health issues, including vision health inequities, the need for improved vision surveillance, the impact of community eye health programs, and disparities in access to affordable eyecare services.

In addition to discussing personal stories, this year’s Eyes on Capitol Hill advocates will ask elected officials to:

  • support a funding level of $5 million in Fiscal Year 2023 for the Vision and Eye Health Budget Line, which provides federal funding for the Centers for Disease Control and Prevention’s (CDC) Vision Health Initiative. The CDC’s Vision Health Initiative (VHI) conducts national-level surveillance, engages in partnerships that promote early detection and connect people at high risk for eye diseases to eye care, and shares best practices with states and communities about incorporating vision and eye health into community-level interventions.
  • maintain the current funding level of the CDC’s glaucoma program at $4 million in FY2023. This funding will allow the CDC to continue glaucoma detection, referral, and treatment programs through community-level partnerships that have successfully reached high-risk and underserved populations and connected them to glaucoma care
  • join the bipartisan, bicameral Congressional Vision Caucus (CVC), dedicated to strengthening and stimulating a national dialogue and policy on vision-related problems and disabilities. The mission of the CVC is to raise awareness about the increasing number of Americans at risk for age-related eye diseases and those who face vision loss due to chronic disease.

The organization also noted that advocates will also urge Congress to pass a final Fiscal Year 2022 bill and include the proposed funding level of $2 million to the VHI. A continuing resolution is set to expire on March 11.

“One of our most important events of the year, Eyes on Capitol Hill is essential to ensure that our policymakers are made aware of the significant impact that vision loss and blindness may have on the ability to succeed in the classroom, continue to work and live independently, as well as maintain mental health and quality of life,” said Jeff Todd, president and CEO of Prevent Blindness. “Through improved national surveillance methods, spread of effective community vision programs, and access to quality eyecare services and treatments, we can work together to help save sight in children, adults and seniors.”

Related Videos
Tips for better contract negotiations for young ophthalmologists
Michael Rivers, MD, director of ophthalmology, Modernizing Medicine, shares what lingers on his mind in the field of ophthalmology at the end of the day.
Michael Rivers, MD, discusses how prior authorization policy affects cataract surgery
Michael X. Repka, MD, vice chair of clinical practice at Wilmer Eye Institute (Johns Hopkins University) speaks with Ophthalmology Times'®  Sheryl Stevenson
© 2024 MJH Life Sciences

All rights reserved.